Search the webpage

Category: Neuroprotection
Animals used for research:   Mouse, Rat  

Organotypic retinal tissue ex vivo provides a simplified model to study retinal cell degeneration and screen promising therapeutics under strictly controlled environmental conditions.1

Indications: Neuroprotection, retinitis pigmentosa

SUMMARY

Animal species

Mice, rats

Follow-up period

Up to 14 days

Route of compound administration

In the serum-free media

Read-outs
  • Ex vivo functional assessment;
  • Morphological assessment;
  • Molecular biology (ELISA, Western blotting, qPCR).
Please contact us, if you would like to receive more information: info@experimentica.com

IMAGES

simplified overview of methodologies used for ex vivo retinal explant studies

Figure 1.  An overview of employed methodology to study ex vivo retinal explants. 1) Evaluation of retinal thickness and glial/microglial activation from retinal sections; 2) Estimation of the total number of neurons/astrocytes/microglial cells using stereology; 3) Functional evaluation of retinal tissue using multi-electrode array system.

SELECTED PUBLICATIONS

  • Nymark S, Ragauskas S, Savolainen V, Holme A, Hyttinen JAK, Kalesnykas G. Morphological and functional characterization of ex vivo retinal explants from adult mice. Investigative Ophthalmology & Visual Science, 2014, April, Vol. 55, 2377.

REFERENCES

  1. Bull ND, Johnson TV, Welsapar G, DeKorver NW, Tomarev SI, Martin KR. Use of an adult rat retinal explant model for screening of potential retinal ganglion cell neuroprotective therapies. Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3309-20. doi:10.1167/iovs.10-6873.

Leave a Comment

LATEST NEWS

Meet Us at ARVO 2018

News
Email info@experimentica.com to set up a One-on-One meeting ... Read More

Meet us at the 2018 Bio Asia International conference

News
Experimentica Ltd. co-sponsors the 2018 Bio Asia International conference, to be held in Tokyo, Japan, March 19-20, 2018 ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers to!